| Logo | Name | Σ |
|---|---|---|
 | Pierre Fabre Laboratories New ways to care Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale … Sectors: Pharmaceutical | 821 |
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: Pharmaceutical | 3675 |
 | MEDICALPS The cluster of health arc health technologies Medicalps is the cluster of health arc health technologies. Since 2000, the association has brought together and represents a network of more than 130 start-ups, SMEs, large groups, research centers, university and communities from the fields of medical technologies, biotechnologies and e-health. The leadership of Medicalps, animator and unifying of this community, is largely entrusted to entrepreneurs, with the support of public actors, with the aim of building the medicine of tomorrow. The association's operational programs are to the growth and visibility services of the Industrial Network of the Alpine Sillon Health Technologies. … | 206 |
 | Centre-Val de Loire Region Activity, Employment, Environment, Solidarity at the Heart of the Center-Val de Loire Région's Challenges for the Future A flagship place of creation, innovation and the art of living, the Center-Val de Loire region has been, since the Renaissance, that which best has been the best-culture and heritage DNA. Strongly marked by its agriculture, the Center-Val de Loire region is one of the 1st cereal regions of Europe. They are also renowned for its international renowned competitiveness clusters: the Cosmetic Valley (perfumery and cosmetics), the electrical energy and systems pole (renewable energies, intelligent buildings and electrical equipment and products) and elastopôle … Sectors: National and local authorities | 1894 |
 | CNRS Innovation Filiale du CNRS & de BPI France. 30 ans d'expertise au service de l'innovation et du transfert de technologies. CNRS Innovation, established in 1992, is a French public limited company, now a subsidiary of the CNRS at 90% and 10% Bpifrance Financement. Its mission is to transfer innovative technologies, mainly originating from the CNRS, to the industry. Its action extends from the receipt of projects to the granting of exploitation rights through consulting in Intellectual Property strategies, participation in the filing of patent applications, seeking of industrial partners, negotiating and drafting of exploitation agreements, and management of patent portfolios. CNRS … Sectors: Research | 558 |
 | CNRS The French National Centre for Scientific Research is among the world's leading research institutions. Its scientists explore the living world, matter, the Universe, and the functioning of human societies in order to meet the major challenges of today and tomorrow. Internationally recognised for the excellence of its scientific research, the CNRS is a reference in the world of research and development, as well as for the general public. Recherche scientifique, Biologie, Chimie, Ecologie et environnement, Ingénierie et systèmes, Mathématiques, Physique, Sciences de l'information, Homme et société, Nucléaire et particules, Terre et Univers, and Science Sectors: Research | 3466 |
 | MSD At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse … Sectors: Pharmaceutical | 2160 |
 | Clermont Auvergne Innovation Innovation accelerator Clermont Auvergne Innovation, a valuation subsidiary, is responsible for ensuring the interface between research laboratories of Clermont Auvergne and associates and its partners, whose companies, by simplifying and accelerating collaboration processes in order to increase the number of these interactions. Our goal is to enhance the assets and skills of the scientific community to companies until the creation of Deeptech start-ups. Technology transfer, innovative technology maturation, and protection of invention patents Sectors: Research | 90 |
 | Atlanpole Biotherapies Thinking up tomorrow's medicine Atlanpole Biotherapies is a French biocluster that gives you access to extended skills, from biodiagnostic to biomedicine. For pharmaceutical and biotech companies or research laboratories looking for high level partners committed to healthcare and biotechnologies, Atlanpole Biotherapies is a biocluster that draws together a network of industrial and academic competences which offers comprehensive and competitive solutions along the entire biotherapeutic value chain, from discovery to patient,within 4 areas of excellence: • immunobiotherapies • radiopharmaceuticals • biomaterials • cell & gene therapies More information : http://www.atlanpolebiotherapies.com Biotechnologies, Bioproduction, Pharma, Technologies médicales innovantes, MedTech, Numérique pour la santé, … Sectors: Biotechnology French Cluster Public business cluster | 330 |
 | Institut Carnot CALYM Consortium dedicated to partnership-based research on lymphomas CALYM is a consortium of organisations dedicated to lymphoma research, acknowledged as “Carnot Institute” since 2011: these are public/parapublic research institutes strongly committed to developing partnership-based research with the socio-economical sphere. CALYM was born from the wish shared by several research organisations to create a Consortium for the Acceleration of innovation and its transfer in the field of LYMphoma research. It currently includes 20 organisations with complementary expertise in preclinical, translational and clinical lymphoma research: 2 non-profit associations: – The Lymphoma Study Association (LYSA), a cooperating group that is the international leader of … | 115 |
 | Medicen Paris Region Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and … Sectors: French Cluster Public business cluster | 723 |
 | Lyonbiopôle Auvergne-Rhône-Alpes The health innovation network As a French leading biocluster, Lyonbiopole Auvergne-Rhône-Alpes aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges. Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients. Sectors: Biotechnology French Cluster Public business cluster | 507 |
 | Eurobiomed The service catalyst for the community of healthcare innovators in the south of France. Created in 2005, the Eurobiomed competitiveness cluster helps to unite and position the healthcare ecosystem of the Provence-Alpes-Côte-d'Azur and Occitanie/Pyrénées-Méditerranée regions at the cutting edge of innovation. Its aim is to foster the growth and projects of innovative healthcare companies in the region. From immunology and dermatology to neurology, oncology and digital health, Eurobiomed supports French and European public economic development strategies, helping to position its members as European champions and anchor France among the world leaders in healthcare innovation. Eurobiomed brings together all healthcare players, … Sectors: Biotechnology French Cluster Public business cluster | 479 |
 | BioValley France Pôle de compétitivité santé du Grand Est Pôle de compétitivité Santé du Grand Est, BioValley France (ex Alsace BioValley) a pour mission de fédérer, développer et faire rayonner les acteurs de la filière à travers l’Innovation. Le Pôle s’appuie sur un réseau dynamique d’entreprises, une recherche académique et clinique de premier plan, ainsi qu’un réseau intégré de partenaires, acteurs-clés de l’innovation. BioValley France accompagne ses membres dans leur démarche d’Innovation R&D et leur permet d’accéder à des expertises à forte valeur ajoutée, dans une approche marché. BioValley France participe activement aux projets structurants et collaboratifs du territoire. Il contribue notamment … Sectors: Biotechnology French Cluster Public business cluster | 484 |
 | La Région Occitanie / Pyrénées-Méditerranée Official page of the Occitanie region. Here you will find economic news, aid and calls for projects. The Occitanie / Pyrénées-Méditerranée region brings you the right info to succeed in your business or training projects: agenda, news, testimonies, files ... also find the region on www.laregion.fr Sectors: National and local authorities | 3821 |
 | Région Auvergne-Rhône-Alpes #Auvergnerhonealpes Auvergne-Rhône-Alpes is a large region that has many advantages: - With more than 8 million inhabitants, it is more populated than 13 of the 28 countries of the European Union and ranks 10th region most populated in Europe - covering nearly 70,000 km2, or 13 % of the metropolitan territory, its area is equivalent to that of Ireland. - In France, it is the first industrial and gastronomic region, it ranks first for agricultural productions under label (AOP, IGP, etc.) and the number of organic farms. - In Europe: it is the 8th richest region in Europe with a … Sectors: National and local authorities | 4463 |
 | MAME Tours City of creation and innovation in Tours. Place totem of the French Tech Val de Loire, Mame is an ecosystem at the service of entrepreneurs, which meets the conditions of success, catalyst for meetings, third places at the crossroads of the economic and cultural dynamics of the territory. | 188 |
 | Leem The professional organization of drug companies operating in France. Leem, medication companies, brings together companies in the pharmaceutical industry in France. Created over 130 years ago, the Leem now has nearly 270 adhering companies, which have almost 98 % of the total medication turnover in France. The pharmaceutical industry employs 100,000 people in more than 150 trades, and has recruited 10,000 employees per year for 10 years. Each year, the pharmaceutical industry invests 12 % of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its R & AMP; D … Sectors: Startup accelerator & VC | 755 |
 | PMT - pôle des microtechniques Catalyze innovation, accelerate business & amp; Support the transitions of industrial companies in BFC Competitiveness center since 2005, the PMT catalyzes innovation, has accelerates business and supports the transitions of industries in Burgundy-Franche-Comté. Since 2017, he has been federating thanks to his PMT Health and PMT ASD clusters, the health technology fields on the one hand and aeronautics-space-defense on the other hand, from excellence in microotechnics. It also developed a strong competence in support dedicated to start-ups and innovative companies through its propellant PMT. Microtechnics, health, aeronautics, defense, space, precision mechanics, luxury, innovation, international, labeling, training, medical, burgundy-Franche-Comté, and precision … Sectors: French Cluster Public business cluster | 332 |
 | Genopole Genopole, biocluster leader en France, Vivre l'innovation Created in 1998, Genopole® has a threefold mission: - develop a high-level research campus in genomics and post-genomics, focused on gene therapy in collaboration with the University Evry-Paris Saclay, - encourage the start-up and foster the development of biotech companies in the Paris region by providing personalized advice and support, including financial assistance - create a biopark in Evry-Courcouronnes in collaboration with the research campus. biocluster, research campus - academical laboratories, biotech companies, university, life sciences companies, Infrastructure - Shared-use technology platforms, and Biotherapy Sectors: Biotechnology | 343 |
 | France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: Biotechnology Startup accelerator & VC | 938 |
 | Johnson & Johnson At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals Sectors: Pharmaceutical | 4634 |
 | CEA Tech From research to industry At CEA Tech we feel strongly that technology research is a crucial component of both innovation and value creation. It is this belief that has driven our successful technology development activities over the past 50 years. CEA Tech is the CEA’s (the French Atomic Energy and Alternative Energy Commission) technology research unit. CEA Tech’s three labs—Leti, Liten, and List—develop a broad portfolio of technologies for ICTs, energy, and healthcare. CEA Tech leverages a unique innovation-driven culture and unrivalled expertise to develop and disseminate new technologies for industry, effectively bridging the gap between the worlds of research … | 115 |
 | Cryoport Systems (formerly Cell&Co) A Cryoport Company - ATMP & Clinical sample management - www.cell-and-co.com Expert in GMP products management & Clinical sample management activities, Cell&Co BioServices, subsidiary of Cryoport Systems, offers a complete one-stop-shop solution for managing GMP-products and biological-samples. Our mission is to give you a reliable solution of storage, packaging, traceability, and trustfull logistic services. Cell&Co is the first and most important french private biorepository ; recognized, certified and having regulatory authorizations, with the highest and non challenged capacity. With two GMP plants, Cell&Co is offering mirroring storage capacities from -196°C to +20°C. We mainly support our clients by providing the … Sectors: Biotechnology | 18 |
 | Boehringer Ingelheim Our people are our strength. And, together with over 54,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Privacy Notice: https://www.boehringer-ingelheim.com/privacy-notice Imprint: https://www.boehringer-ingelheim.com/imprint Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing Sectors: Animal Health Pharmaceutical | 1964 |
 | XAnge XAnge (xange.vc) is a leading European venture capital firm, Bcorp certified, based in Paris, Berlin, and Brussels. With €650M Assets under Management, the company invests in European early-stage innovative technology companies operating in the fields of Enterprise & Data, Fintech, and Deep Tech. Since its creation in 2003, XAnge has backed more than 200 fast-growing companies in their entrepreneurial journeys. The team works alongside visionary founders with strong values and international ambitions such as Ledger, Odoo, Lydia, or Believe Digital. Venture Capital, Digital, Social Impact, Fintech, BtoB, Cloud, Deep Tech, and Blockchain Sectors: Startup accelerator & VC | 735 |
 | Gouvernement The official account of the French Government Follow Government news on this page in real time, including practical information, measures, numbers, results, and the profiles of economic players ! | 2627 |
 | Eurazeo Eurazeo is a leading global investment group Eurazeo is a leading global investment company, with a diversified portfolio of €34.1 billion in assets under management, including nearly €24.1 billion from third parties, invested in 590 companies. With its considerable private equity, private debt as well as real estate and infrastructure asset expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its nearly 410 professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free … Sectors: Finance | 1001 |
 | CEA The CEA is the French Alternative Energies and Atomic Energy Commission ("Commissariat à l'énergie atomique et aux énergies alternatives"). It is a public body established in October 1945 by General de Gaulle. A leader in research, development and innovation, the CEA mission statement has two main objectives: To become the leading technological research organization in Europe and to ensure that the nuclear deterrent remains effective in the future. The CEA is active in four main areas: low-carbon energies, defense and security, information technologies and health technologies. In each of these fields, the CEA maintains a cross-disciplinary culture of engineers and … Sectors: Research | 2885 |
 | bioMérieux Pioneering Diagnostics A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety. in vitro … Sectors: Biotechnology | 466 |
 | Institut Curie Together, let's take speed cancer A recognized foundation of public utility, the Curie Institute associates one of the largest European research centers in cancerology and two cutting -edge hospitals. Founded in 1909 on a model designed by Marie Curie and still avant-garde, "from basic research to innovative care", the Institut Curie brings together 3,000 researchers, doctors, caregivers, technicians and administratives. Care The hospital ensemble of the Curie Institute is a reference center for breast cancers, eye tumors and pediatric cancers in particular. Research To advance the prevention, diagnosis and treatment of cancers, biologists, chemists, physicists, bio-informatians and doctors are mobilizing, … Sectors: Health | 988 |
 | La French Tech 🇫🇷 La French Tech est la marque déployée par l’Etat français qui représente l’écosystème de 25 000 start-up françaises et de tous les acteurs qui gravitent autour (fonds d’investissement, associations, acteurs publiques, etc.), soutenus par la Mission French Tech (administration rattachée à la Direction Générale des Entreprises, au sein du ministère de l’Economie, des Finances et de l'Industrie). Elle a pour mission d’accompagner le développement de l’écosystème French Tech, mouvement français des start-up technologiques innovantes, dans la lignée des priorités gouvernementales, à l’image et au service des Françaises et des Français. Pour ce faire, elle rassemble cet écosystème aux côtés … Sectors: Media | 4207 |
 | PULSALYS Incubate the startups Deeptech & amp; Accelerates the scientific innovations of the R & Amp; D Lyon-St Labos 🚀 Pulsalys, incubator and accelerator of Deep Tech innovations in Lyon & amp; St Etienne, builds products & amp; Innovative services of tomorrow, by transforming scientific discoveries from the University of Lyon laboratories into economic opportunities for businesses and startups. Created in December 2013 as part of the Investment Program for the Future (PIA) under the status of Acceleration Society for Technology Transfer (SATT), Pulsalys has become a key player in the attractiveness and economic development of the Lyon - St -Etienne … Tags: SATT Network Sectors: Research | 447 |
 | Linksium Detecting promising #deeptech and fostering the creation of #startups with Grenoble Alpes IP inside . Linksium, Société d’Accélération du Transfert de Technologies (SATT) de Grenoble Alpes détecte projets prometteurs issus de la recherche publique, finance et accompagne la création de startups #deeptech. Detecting promising technologies, funding and fostering the creation of deeptech #startups in the French Alps area. Technology transfert, Startups building, deeptech, venture capital, Research & development , and R&D Tags: SATT Network | 402 |
 | Hello Tomorrow Building a collaborative ecosystem that leverages the power of deep technologies to tackle world challenges. Hello Tomorrow was created in 2011 by a group of individuals convinced that science and technology need to form part of a toolkit of solutions to change our industries, sustain a growing population and help solve global crises. But the traditional model of technology transfer to bring solutions from lab to market, and from idea to impact, could not rise to this challenge. In turn, Hello Tomorrow has built, and now animates, a global ecosystem that facilitates ‘deep tech’ innovation through multiple activities. Over the … Sectors: Trade show | 698 |
 | Business France Business France is the national agency for the internationalization of the French economy. It is responsible for the international development of companies and their exports, as well as prospecting for and welcoming international investments in France. It promotes the attractiveness and business image of France, its companies and its territories. It manages and develops the V.I.E (Volontariat International en Entreprise). Created on January 1, 2015, Business France is a merger of UBIFRANCE and the AFII (French Agency for International Investments). Business France has 1,500 employees located in France and in 70 countries. It relies on a network of public and … Sectors: National and local authorities | 5598 |
 | Bayer Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by … Tags: DAX30 Sectors: Chemistry Pharmaceutical | 4851 |
 | Bpifrance Bpifrance account, the public investment bank. Bpifrance, public investment bank, supports businesses, from priming to stock market quotes, from credit to equity. A privileged interlocutor, Bpifrance offers in each region financing or investment solutions adapted to each stage of business life. Bank partner of entrepreneurs, Bpifrance supports them sustainably to support their growth and competitiveness. The teams are at the heart of the regions, throughout the territory, through more than 50 regional locations. Financing of SMEs, business creation, international development, investment, creation/transmission, innovation, support, acceleration, and export guarantee Sectors: Bank | 13084 |
 | UCB Inspired by patients. Driven by science. UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and … | 357 |
 | BASF We create chemistry for a sustainable future At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. Around 112,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of €68.9 billion in 2023. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States. Credits: https://www.basf.com/global/en/legal/credits Data … | 4153 |
 | GSK We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines Sectors: Pharmaceutical | 1183 |
 | MOVE: Mobility Re-imagined MOVE is mobility’s #1 innovation event, connecting the entire ecosystem of mobility. MOVE is mobility’s #1 innovation event, connecting the entire ecosystem of mobility. MOVE is a one-of-a-kind event bringing together the people and companies redefining mobility across the ecosystem. We pride ourselves on being able to facilitate critical cross sector partnerships and conversations that are critical to move the industry forward. MOVE connects the entire mobility ecosystem, focused on tech, innovation and transformation. The event provides unparalleled opportunity for every vertical within the ecosystem to come together, learn, partner, innovate and push boundaries. Our MOVE community gets together twice … | 317 |
 | Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: Biotechnology Pharmaceutical | 1672 |
 | Servier Pharmaceuticals Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to … Sectors: Pharmaceutical | 602 |
 | Pfizer We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them. Sectors: Pharmaceutical | 1484 |
 | Novo Nordisk Get updates around our progress and challenges to champion long-term health 💙 #DrivingChange Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments … Sectors: Pharmaceutical | 1476 |
 | Merck Group This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, … Tags: DAX30 Sectors: Biotechnology Pharmaceutical | 1541 |